IRIS
SCICALI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.872
AS - Asia 1.796
EU - Europa 1.655
SA - Sud America 426
AF - Africa 354
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 8.105
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.781
IT - Italia 1.002
SG - Singapore 709
CN - Cina 641
BR - Brasile 379
CI - Costa d'Avorio 239
IE - Irlanda 235
KR - Corea 130
IN - India 103
VN - Vietnam 96
SN - Senegal 75
CA - Canada 64
DE - Germania 63
GB - Regno Unito 60
UA - Ucraina 52
SE - Svezia 47
RU - Federazione Russa 46
FI - Finlandia 40
TR - Turchia 23
PL - Polonia 21
NL - Olanda 20
MX - Messico 19
FR - Francia 17
HK - Hong Kong 17
AR - Argentina 15
JP - Giappone 15
NG - Nigeria 13
UZ - Uzbekistan 11
AT - Austria 10
ES - Italia 9
BD - Bangladesh 8
CL - Cile 8
MA - Marocco 8
ZA - Sudafrica 8
IQ - Iraq 7
PK - Pakistan 7
CO - Colombia 6
EC - Ecuador 5
LT - Lituania 5
BG - Bulgaria 4
CH - Svizzera 4
PY - Paraguay 4
VE - Venezuela 4
BE - Belgio 3
GR - Grecia 3
ID - Indonesia 3
KE - Kenya 3
PE - Perù 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GD - Grenada 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
LB - Libano 2
OM - Oman 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
IS - Islanda 1
KW - Kuwait 1
LK - Sri Lanka 1
MK - Macedonia 1
MN - Mongolia 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TZ - Tanzania 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.105
Salva come PNG Salva come JPEG
Città #
Dallas 921
Santa Clara 700
Singapore 461
Chandler 431
Chicago 275
Hefei 260
Abidjan 239
Dublin 232
Catania 206
Ashburn 167
Civitanova Marche 150
Seoul 130
Boardman 121
Beijing 107
Rome 86
Kochi 81
Dakar 75
Los Angeles 70
Cambridge 65
Lawrence 59
Andover 57
Jacksonville 56
Dong Ket 51
Wilmington 42
Milan 41
Des Moines 33
São Paulo 30
Nanjing 28
Toronto 28
New York 25
Bremen 24
Palermo 24
Lappeenranta 22
The Dalles 21
Ho Chi Minh City 20
Carrara 19
Padova 19
Montreal 18
Warsaw 18
Belo Horizonte 17
Houston 17
Hong Kong 15
Tokyo 15
Messina 14
Munich 14
Saint Petersburg 14
Seattle 14
Stockholm 14
Columbus 13
San Francisco 13
Abuja 12
Brooklyn 12
Menlo Park 12
Hanoi 11
Shenyang 11
Turku 11
Brasília 10
Council Bluffs 10
Gravina di Catania 10
Hebei 10
Manchester 10
Bari 9
Boston 9
Denver 9
London 9
Rio de Janeiro 9
San Mateo 9
Washington 9
Ankara 8
Istanbul 8
Naples 8
Orem 8
Ottawa 8
Reggio Emilia 8
Atlanta 7
Chennai 7
Helsinki 7
Pollenza 7
Poplar 7
Querétaro 7
Città Sant'Angelo 6
Enna 6
Johannesburg 6
Leawood 6
Mascalucia 6
Mexico City 6
Phoenix 6
Salvador 6
Tashkent 6
Aci Sant'Antonio 5
Amsterdam 5
Civitavecchia 5
Curitiba 5
Guangzhou 5
Jiaxing 5
Nanchang 5
Ragusa 5
Sankt Augustin 5
Shanghai 5
Tianjin 5
Totale 5.953
Salva come PNG Salva come JPEG
Nome #
Glucose metabolism in heterozygous familial hypercholesterolemia with a founder effect and a high diabetes prevalence: a cross-sectional study 324
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 197
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 140
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 132
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 129
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 129
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 126
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 116
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 113
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 111
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 108
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 108
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 107
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 106
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 103
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 102
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 101
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 100
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 99
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 96
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 96
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 95
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 94
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 94
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 94
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 93
Clinical and molecular biomarkers for diagnosis and staging of nafld 91
Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome 90
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 89
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 89
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 88
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 87
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 86
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 85
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy 84
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 82
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 82
Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease 81
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation 81
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 81
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience 81
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting 79
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 77
Cardiovascular risk profile in subjects with diabetes: Is SCORE2-Diabetes reliable? 77
Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 77
HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients 75
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 75
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 75
Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department 73
High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications 69
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis 68
Corticosteroid replacement therapy in hepatoadrenal syndrome: case report with a review of the literature. 68
Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: a possible role in glucocorticoid deficiency 68
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress 68
Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels 67
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 67
Comparison of Total Cortisol, Free Cortisol, and Surrogate Markers of Free Cortisol in Diagnosis of Adrenal Insufficiency in Patients with Stable Cirrhosis. 67
Left ventricular geometry and periodontitis in patients with the metabolic syndrome 67
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 67
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects 67
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 67
The impact of obesity and dyslipidemia on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study 67
Increased Platelet Reactivity and Proinflammatory Profile Are Associated with Intima-Media Thickness and Arterial Stiffness in Prediabetes 67
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 67
PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk 66
Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications 66
Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice 66
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 66
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 65
Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units 65
Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile 64
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 63
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy 63
L'emoglobina glicosilata, meglio della curva da carico, permette l'identificazione di soggetti con prediabete ed elevato rischio cardiovascolare 61
Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN) 61
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group 60
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 60
Endothelial Dysfunction and Heart Failure with Preserved Ejection Fraction—An Updated Review of the Literature 58
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 58
Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies 57
Triglycerides to high density lipoprotein cholesterol ratio (TG/HDL), but not triglycerides and glucose product (TyG) index, is associated with arterial stiffness in prediabetes 57
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network 57
Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study 57
May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects? 57
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways 57
Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease 57
Studio dell'effetto incretinivo e della funzione beta cellulare in soggetti con prediabete e diabete di neo diagnosi 55
Is the relationship between erythropoiesis and renal function one of the secrets of extreme longevity? 54
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 54
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 54
Impatto del profilo lipidico sulla malattia aterosclerotica in due differenti coorti di pazienti ad alto rischio cardiovascolare 53
Author's reply to: Arterial stiffness improvement after adding on PCSK9 inhibitors in patients with familial hypercholesterolemia, a letter from Papaioannou and colleagues 53
Clinical evaluation of bempedoic acid for the treatment of hyperlipidaemia 52
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units 52
Efficacy of combined therapy with GLP1-RA and SGLT2-I in poorly controlled type 2 diabetes 51
Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies 51
Real-world efficacy of combination therapy with GLP1-RA and SGLT2-I in type 2 diabetes subjects with inadequate glucose control 50
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 48
Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience 48
Diagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group 47
Totale 8.072
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.393
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021232 0 0 0 5 46 15 19 3 14 37 31 62
2021/2022529 37 56 1 21 89 38 69 41 27 7 20 123
2022/20231.105 68 93 33 136 105 169 5 190 212 14 41 39
2023/2024791 36 118 49 27 45 163 52 88 10 27 103 73
2024/20252.921 69 396 138 259 548 387 134 77 144 225 336 208
2025/20262.426 382 447 1.120 477 0 0 0 0 0 0 0 0
Totale 8.329